Frequently Bought Together
Designed for STR genotyping, this antibody-mediated hot-start enzyme combines Hieff UNICON™ Taq Antibody with Hieff™ Taq DNA Polymerase. The antibody keeps polymerase activity blocked even after 30 minutes at 50℃ and is fully inactivated within 30 seconds at the initial denaturation temperature, releasing active polymerase. This helps minimize amplification caused by nonspecific primer annealing. The thermostable recombinant polymerase has high template affinity, making it well suited to low-copy-number targets. Formulation additives further improve blocking efficiency and room-temperature stability.
Feature
Excellent stability: Contains additives that enhance blocking efficiency, providing good room-temperature stability.
High amplification efficiency: Thermostable recombinant DNA polymerase with high template affinity, ideal for low-copy template amplification.
Broad applicability: Suitable for conventional PCR, hot-start PCR, qPCR, and high-throughput sequencing.
Components
|
Cat. No. |
Name |
14226ES72 (500 U) |
14226ES80 (5000 U) |
14226ES92 (25000 U) |
14226ES93 (50000 U) |
14226ES94 (100000 U) |
|
14226 |
HotStart Taq DNA Polymerase (5 U/μL) |
100 μL |
1 mL |
5 mL |
10 mL |
20 mL |
Application Examples
1. Amplification Performance
A positive control from a forensic testing kit was amplified using YEASEN Taq polymerase 14226 and comparable commercial enzymes. Under the conditions tested, 14226 produced higher overall peak heights, indicating stronger detection performance.
Figure 1. Amplification performance comparison.
2. Specificity
No-template controls (NTCs) were tested using YEASEN Taq polymerase 14226 and two comparable commercial enzymes. The 14226 reactions showed no nonspecific peaks, while both comparator enzymes produced nonspecific peaks to varying degrees, demonstrating higher specificity under the conditions tested.
Figure 2. Specificity comparison in no-template controls.
Storage
FAQ
Citations
Applications
Du kan også lide
Forespørgsel
FAQ
Produktet er kun til forskningsformål og er ikke beregnet til terapeutisk eller diagnostisk brug hos mennesker eller dyr. Produkter og indhold er beskyttet af patenter, varemærker og ophavsrettigheder ejet af Yeasen Biotechnology. Varemærkesymboler angiver oprindelseslandet, ikke nødvendigvis registrering i alle regioner.
Visse applikationer kan kræve yderligere tredjeparts intellektuelle ejendomsrettigheder.
Yeasen er dedikeret til etisk videnskab og mener, at vores forskning bør adressere kritiske spørgsmål og samtidig sikre sikkerhed og etiske standarder.